Gene: PLTP

5360
BPIFE|HDLCQ9
phospholipid transfer protein
protein-coding
20q13.12
Ensembl:ENSG00000100979 MIM:172425 Vega:OTTHUMG00000033047 UniprotKB:P55058
NG_012115.1
PubMed
0   ANCO-SNPs
ND
12   
3.879e-1 (AD)  6.524e-1 (ND)   (Frontal_Cortex)
6.006e-1 (AD)  5.752e-1 (ND)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
PLEKHO20.913
FKBP100.908
RAB340.895
EZR0.885
ITGB50.885
AXL0.883
EFEMP20.878
S1PR10.874
ARHGEF400.871
PLD20.869

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
GABRG3-0.535
IL12RB2-0.507
TYRP1-0.504
PAQR9-0.495
ZNF860-0.494
EPHA5-0.489
GPR61-0.485
ANKRD34C-0.484
MUM1L1-0.484
CALHM1-0.483

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C0284741,4-bis(2-(3,5-dichloropyridyloxy))benzene"1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in decreased expression of PLTP mRNA"28903501
C0291412,2,5,7,8-pentamethyl-1-hydroxychroman"2,2,5,7,8-pentamethyl-1-hydroxychroman results in decreased expression of PLTP mRNA"21920950
C0140242,4,5,2',4',5'-hexachlorobiphenyl"[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of PLTP mRNA"28433925
C0095054,4'-diaminodiphenylmethane"4,4'-diaminodiphenylmethane results in increased expression of PLTP mRNA"25380136
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLTP mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLTP mRNA"27188386
D000082AcetaminophenAcetaminophen results in increased expression of PLTP mRNA22230336
D000082Acetaminophen[Clofibrate co-treated with Acetaminophen] affects the expression of PLTP mRNA17585979
D000082AcetaminophenPPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of PLTP mRNA]17585979
D016604Aflatoxin B1Aflatoxin B1 affects the expression of PLTP protein20106945
D016604Aflatoxin B1Aflatoxin B1 results in increased expression of PLTP mRNA21632981|2164198
D016604Aflatoxin B1Aflatoxin B1 results in decreased expression of PLTP mRNA19770486
D000517alpha-Chlorohydrinalpha-Chlorohydrin results in increased expression of PLTP mRNA28522335
D013196DihydrotestosteroneDihydrotestosterone results in decreased expression of PLTP mRNA17023530
D024502alpha-TocopherolPLTP mutant form results in decreased abundance of alpha-Tocopherol16675720
D000638AmiodaroneAmiodarone results in increased expression of PLTP mRNA24535564
D018501Antirheumatic AgentsAntirheumatic Agents results in decreased expression of PLTP mRNA24449571
D001151ArsenicArsenic affects the methylation of PLTP gene25304211
C006632arsenic trioxidearsenic trioxide results in decreased expression of PLTP mRNA19128835
D001280AtrazineAtrazine results in increased expression of PLTP mRNA22378314
D001564Benzo(a)pyreneBenzo(a)pyrene results in increased expression of PLTP mRNA20106945|2163298
D001564Benzo(a)pyreneBenzo(a)pyrene results in increased expression of PLTP mRNA21964900
D0151237,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of PLTP mRNA"20382639
D004958EstradiolEstradiol results in increased expression of PLTP mRNA19484750
D001629BezafibrateBezafibrate results in decreased activity of PLTP protein12754275
D001629Bezafibrate"[Bezafibrate results in decreased activity of PLTP protein] affects the reaction [Bezafibrate results in decreased abundance of Fatty Acids, Nonesterified]"12754275
C543008bis(4-hydroxyphenyl)sulfone[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of PLTP mRNA28628672
C006780bisphenol Abisphenol A affects the expression of PLTP mRNA21786754
C006780bisphenol Abisphenol A results in increased expression of PLTP mRNA29275510
C006780bisphenol A[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PLTP mRNA28628672
C006780bisphenol A"[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of PLTP mRNA"28433925
C006780bisphenol Abisphenol A results in decreased expression of PLTP mRNA25181051
C018475butyraldehydebutyraldehyde results in increased expression of PLTP mRNA26079696
D019256Cadmium ChlorideCadmium Chloride results in decreased expression of PLTP mRNA25993096
C459604candoxincandoxin results in decreased expression of PLTP mRNA16309724
D002251Carbon TetrachlorideCarbon Tetrachloride affects the expression of PLTP mRNA17484886
C100187chloropicrinchloropicrin results in increased expression of PLTP mRNA26352163
D008076Cholesterol, HDL"PLTP protein affects the abundance of Cholesterol, HDL"12754275
D002994Clofibrate[Clofibrate co-treated with Acetaminophen] affects the expression of PLTP mRNA17585979
D002994ClofibratePPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of PLTP mRNA]17585979
D002995Clofibric Acid[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of PLTP mRNA17602206
D019327Copper SulfateCopper Sulfate results in decreased expression of PLTP mRNA19789285
D019327Copper SulfateCopper Sulfate results in increased expression of PLTP mRNA19789285
D003471CuprizoneCuprizone results in increased expression of PLTP mRNA26577399
D003561CytarabineCytarabine results in decreased expression of PLTP mRNA21198554
D003907Dexamethasone[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of PLTP mRNA28628672
D003907Dexamethasone[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PLTP mRNA28628672
D003907Dexamethasone[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PLTP mRNA28628672
D003907Dexamethasone[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of PLTP mRNA16054899
D003907DexamethasoneEGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of PLTP mRNA]16054899
D003907DexamethasoneTetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of PLTP mRNA]16054899
D002945Cisplatin[Cisplatin co-treated with jinfukang] results in increased expression of PLTP mRNA27392435
D002945CisplatinCisplatin results in increased expression of PLTP mRNA27392435
D002945Cisplatin[Cisplatin co-treated with RELB mutant form] results in decreased expression of PLTP mRNA23625948
D004041Dietary FatsDietary Fats affects the expression of PLTP mRNA19680557
D004041Dietary Fats[Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of PLTP mRNA28433925
D004041Dietary FatsDietary Fats results in decreased expression of PLTP mRNA15238619|1804283
D004041Dietary FatsDietary Fats results in increased expression of PLTP mRNA25016146
D019422Dietary Sucrose[Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of PLTP mRNA28433925
D004051Diethylhexyl PhthalateDiethylhexyl Phthalate results in increased expression of PLTP mRNA19245819|1985064
D004051Diethylhexyl PhthalatePPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of PLTP mRNA]19850644
D004051Diethylhexyl Phthalate"[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of PLTP mRNA"28433925
D004052DiethylnitrosamineDiethylnitrosamine results in increased expression of PLTP mRNA17854601
D004052DiethylnitrosamineRB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of PLTP mRNA]17854601
D004052Diethylnitrosamine[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of PLTP mRNA17602206
D002117CalcitriolCalcitriol results in decreased expression of PLTP mRNA26485663
D004237DiuronDiuron results in decreased expression of PLTP mRNA25152437
C118739entinostatentinostat results in increased expression of PLTP mRNA26272509
C118739entinostat"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLTP mRNA"27188386
D004997Ethinyl EstradiolEthinyl Estradiol affects the expression of PLTP mRNA17555576
D004997Ethinyl EstradiolEthinyl Estradiol results in decreased expression of PLTP mRNA17942748
D004997Ethinyl EstradiolEthinyl Estradiol affects the expression of PLTP mRNA26379055
C024565ethylene dichlorideethylene dichloride results in decreased expression of PLTP mRNA28189721
D005228Fatty Acids, Essential"Fatty Acids, Essential deficiency results in increased expression of PLTP mRNA"23333450
D005228Fatty Acids, Essential"NR1H2 gene mutant form inhibits the reaction [Fatty Acids, Essential deficiency results in increased expression of PLTP mRNA]"23333450
D005228Fatty Acids, Essential"NR1H3 gene mutant form inhibits the reaction [Fatty Acids, Essential deficiency results in increased expression of PLTP mRNA]"23333450
D005230Fatty Acids, Nonesterified"[Bezafibrate results in decreased activity of PLTP protein] affects the reaction [Bezafibrate results in decreased abundance of Fatty Acids, Nonesterified]"12754275
D011345FenofibrateFenofibrate results in increased expression of PLTP mRNA11798191
D005485FlutamideFlutamide results in decreased expression of PLTP mRNA24136188
C069837fullerene C60fullerene C60 results in increased expression of PLTP mRNA19167457
C056933fumonisin B1fumonisin B1 results in increased expression of PLTP mRNA16221962
C473027GW 3965GW 3965 results in increased expression of PLTP mRNA17449538
C425931GW 501516[GW 501516 binds to PPARD protein] which results in increased expression of PLTP mRNA16197558
C000625835HFPO2 compoundHFPO2 compound results in increased expression of PLTP mRNA27553808
C000625836HFPO4 compoundHFPO4 compound results in increased expression of PLTP mRNA27553808
D017313FenretinideFenretinide results in decreased expression of PLTP mRNA28973697
C492448ICG 001ICG 001 results in increased expression of PLTP mRNA26191083
D007213Indomethacin[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of PLTP mRNA28628672
D007213Indomethacin[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PLTP mRNA28628672
D007213Indomethacin[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PLTP mRNA28628672
D015759Ionomycin[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of PLTP mRNA25613284
D0150561-Methyl-3-isobutylxanthine[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of PLTP mRNA28628672
D0150561-Methyl-3-isobutylxanthine[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PLTP mRNA28628672
D0150561-Methyl-3-isobutylxanthine[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PLTP mRNA28628672
D0150561-Methyl-3-isobutylxanthine[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of PLTP mRNA16054899
D0150561-Methyl-3-isobutylxanthineEGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of PLTP mRNA]16054899
D0150561-Methyl-3-isobutylxanthineTetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of PLTP mRNA]16054899
C544151jinfukang[Cisplatin co-treated with jinfukang] results in increased expression of PLTP mRNA27392435
C544151jinfukangjinfukang results in increased expression of PLTP mRNA27392435
C098607JP8 aviation fuelJP8 aviation fuel results in decreased expression of PLTP mRNA16835149
D008070LipopolysaccharidesPLTP affects the susceptibility to Lipopolysaccharides21787334
D008727MethotrexateMethotrexate results in increased expression of PLTP mRNA17379860
D008727MethotrexateMethotrexate affects the expression of PLTP mRNA18502557
D008727MethotrexateMethotrexate results in decreased expression of PLTP mRNA18502557
D037742Nanotubes, Carbon"Nanotubes, Carbon analog results in decreased expression of PLTP mRNA"25554681|2562005
D037742Nanotubes, Carbon"Nanotubes, Carbon results in decreased expression of PLTP mRNA"25554681|2562005
D0150581-Naphthylisothiocyanate1-Naphthylisothiocyanate results in increased expression of PLTP mRNA25380136
C029938nickel sulfatenickel sulfate results in decreased expression of PLTP mRNA16100012
C012655nimesulidenimesulide results in decreased expression of PLTP mRNA24136188
C464660obeticholic acidobeticholic acid results in decreased expression of PLTP mRNA27939613
D010126OzoneOzone results in decreased expression of PLTP mRNA12763052
D000073878Palm OilPalm Oil results in decreased expression of PLTP mRNA18042831
D010269ParaquatParaquat results in decreased expression of PLTP mRNA17215068
D010269ParaquatParaquat affects the expression of PLTP mRNA15493455
C471071perfluorohexanesulfonic acidperfluorohexanesulfonic acid results in increased expression of PLTP mRNA21705711
C023036perfluorooctanoic acidperfluorooctanoic acid results in increased expression of PLTP mRNA17681415
C027579periodate-oxidized adenosineperiodate-oxidized adenosine affects the expression of PLTP mRNA17097637
D010634PhenobarbitalNR1I3 protein affects the reaction [Phenobarbital results in increased expression of PLTP mRNA]19482888
D010634PhenobarbitalPhenobarbital results in decreased expression of PLTP mRNA19270015|2309116
D010634PhenobarbitalPhenobarbital results in increased expression of PLTP mRNA19482888
D010672PhenytoinPhenytoin results in increased expression of PLTP mRNA15136057
D010705PhosgenePhosgene affects the expression of PLTP mRNA16300373
C006253pirinixic acidpirinixic acid results in increased expression of PLTP mRNA11798191|1537516
C006253pirinixic acidPPARA protein promotes the reaction [pirinixic acid results in increased expression of PLTP mRNA]20059764
D011374ProgesteroneProgesterone results in decreased expression of PLTP mRNA23012394
C045950propiconazolepropiconazole results in decreased expression of PLTP mRNA21278054
C513428pyrachlostrobinpyrachlostrobin results in increased expression of PLTP mRNA27029645
D011794QuercetinQuercetin results in increased expression of PLTP mRNA21632981
D015474IsotretinoinIsotretinoin results in increased expression of PLTP mRNA20436886
C089730rosiglitazone[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of PLTP mRNA16054899
C089730rosiglitazoneEGF protein inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of PLTP mRNA]16054899
C089730rosiglitazoneTetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of PLTP mRNA]16054899
D012524SarinSarin results in decreased expression of PLTP mRNA19522546
D012834SilverSilver results in decreased expression of PLTP mRNA27131904
C009277sodium arsenatesodium arsenate results in decreased expression of PLTP mRNA21795629
C017947sodium arsenitesodium arsenite results in decreased expression of PLTP mRNA21512104
C013698tallowtallow affects the expression of PLTP mRNA19680557
D013629TamoxifenTamoxifen affects the expression of PLTP mRNA17555576
D013749Tetrachlorodibenzodioxin"[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of PLTP mRNA"28433925
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of PLTP mRNA]16054899
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of PLTP mRNA19770486|2892240
D013755Tetradecanoylphorbol Acetate[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of PLTP mRNA25613284
D013792ThalidomideThalidomide results in decreased expression of PLTP mRNA26217789
D013853ThioacetamideThioacetamide results in increased expression of PLTP mRNA26222700
C009495titanium dioxidetitanium dioxide results in decreased expression of PLTP mRNA23557971|2776080
C423915TO-901317TO-901317 results in increased expression of PLTP mRNA17449538
D014212TretinoinTretinoin results in decreased expression of PLTP mRNA21934132
D014212TretinoinTretinoin results in increased expression of PLTP mRNA16054129
D014241TrichloroethyleneTrichloroethylene results in increased expression of PLTP mRNA25549359
C016805tris(1,3-dichloro-2-propyl)phosphate"tris(1,3-dichloro-2-propyl)phosphate results in increased expression of PLTP mRNA"26179874
C057693troglitazonetroglitazone results in increased expression of PLTP mRNA28973697
D014635Valproic AcidValproic Acid affects the expression of PLTP mRNA25979313
D014635Valproic AcidValproic Acid results in increased expression of PLTP mRNA23179753|2718838
D014635Valproic AcidValproic Acid affects the expression of PLTP mRNA17292431
D014635Valproic AcidValproic Acid results in increased expression of PLTP mRNA24535564
D014638VanadatesVanadates results in decreased expression of PLTP mRNA22714537
D001335Vehicle EmissionsVehicle Emissions results in increased methylation of PLTP gene25560391

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0005319lipid transporter activity-IDA9132017  
GO:0005548phospholipid transporter activity-IDA9132017  
GO:0008429phosphatidylethanolamine binding-IDA9132017  
GO:0008525phosphatidylcholine transporter activity-IDA9132017  
GO:0019992diacylglycerol binding-IDA9132017  
GO:0031210phosphatidylcholine binding-IDA9132017  
GO:0035620ceramide transporter activity-IDA9132017  
GO:0070300phosphatidic acid binding-IDA9132017  
GO:0097001ceramide binding-IDA9132017  
GO:1901611phosphatidylglycerol binding-IDA9132017  
GO:1904121phosphatidylethanolamine transporter activity-IDA9132017  
GO:1990050phosphatidic acid transporter activity-IDA9132017  
GO ID GO Term Qualifier Evidence PubMed
GO:0006629lipid metabolic process-IEA-  
GO:0006869lipid transport-IDA9132017  
GO:0010189vitamin E biosynthetic process-IEA-  
GO:0010875positive regulation of cholesterol efflux-IDA24369175  
GO:0015914phospholipid transport-IDA9132017  
GO:0030317flagellated sperm motility-IEA-  
GO:0034375high-density lipoprotein particle remodeling-IDA9132017  24369175  
GO:0035627ceramide transport-IDA9132017  
GO ID GO Term Qualifier Evidence PubMed
GO:0005576extracellular region-TAS7654777  
GO:0005615extracellular space-HDA16502470  
GO:0034364high-density lipoprotein particle-IDA9132017  
KEGG ID KEGG Term
hsa03320PPAR signaling pathway
Reactome ID Reactome Term Evidence
R-HSA-174824Plasma lipoprotein assembly, remodeling, and clearanceTAS
R-HSA-382551Transport of small moleculesTAS
R-HSA-8963899Plasma lipoprotein remodelingTAS
R-HSA-8964058HDL remodelingTAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
12889988Moderate hyperalphalipoproteinaemia in a Brazilian population is related to lipoprotein lipase activity, apolipoprotein A-I concentration, age and body mass index. (2004 Jan)Alarcon SBClin Sci (Lond)
16216472Phospholipid transfer protein activity is associated with inflammatory markers in patients with cardiovascular disease. (2006 Jan)Cheung MCBiochim Biophys Acta
7918308Higher plasma lipid transfer protein activities and unfavorable lipoprotein changes in cigarette-smoking men. (1994 Oct)Dullaart RPArterioscler Thromb
15254877Smoking prevents the intravascular remodeling of high-density lipoprotein particles: implications for reverse cholesterol transport. (2004 Jul)Zaratin ACMetabolism
16374627Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitus. (2006 Feb)de Vries RDiabetologia
11300613Role of phospholipid transfer protein and prebeta-high density lipoproteins in maintaining cholesterol efflux from Fu5AH cells to plasma from insulin-resistant subjects. (2001 Feb)Dullaart RPScand J Clin Lab Invest
17553507Low phospholipid transfer protein (PLTP) is a risk factor for peripheral atherosclerosis. (2008 Jan)Schgoer WAtherosclerosis
21347282Genome-wide association study of coronary heart disease and its risk factors in 8,090 African Americans: the NHLBI CARe Project. (2011 Feb 10)Lettre GPLoS Genet
9684753Decreased postprandial high density lipoprotein cholesterol and apolipoproteins A-I and E in normolipidemic smoking men: relations with lipid transfer proteins and LCAT activities. (1998 Jul)Mero NJ Lipid Res
27478449Serum CETP and PLTP activity in middle-aged men living in urban or rural area of the Lower Silesia region. PURE Poland sub-study. (2016 Aug 1)Skoczynska AArch Med Sci
27899788Serum Lipid Transfer Proteins in Hypothyreotic Patients Are Inversely Correlated with Thyroid-Stimulating Hormone (TSH) Levels. (2016 Nov 30)Skoczynska AMed Sci Monit
19876761Protective modulation of carotid atherosclerosis in hyperalphalipoproteinemic individuals. (2010 Jan)Santiago FDInt J Cardiovasc Imaging